The 2021 BSH symposium; Chaired by Dr Karthik Ramasamy; includes: Plenary presentation (Dr Jennifer Pinney): Renal impairment in patients with RRMM and impact of treatment. Reframing expectations for patients with RRMM and Renal Impairment (Dr Neil Rabin): Results from ICARIA-MM: Multinational Clinical Study Comparing Isatuximab in combination with Pomalidomide and Dexamethasone; to Pomalidomide and Dexamethasone in Adult Patients with RRMM including a focus on renal impairment subgroup data. Reframing expectations for elderly and frail patients in RRMM (Dr Ceri Bygrave): Results from ICARIA-MM trial in elderly and frail patients and discussing practical considerations in treating this patient population. Q&A session.
Founded in 1981 in Boston, Massachusetts, EuroAPI evolved from a tiny start-up to one of the world's leading biotech companies, with nearly 10,000 employees and operations in every region of the globe. Acquired by Sanofi in 2011, EuroAPI UK now benefits from the reach and resources of one of the world’s largest pharmaceutical companies, with a shared commitment to improving the lives of patients.
